Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 12-Month Low at $51.60

Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTFGet Free Report) hit a new 52-week low on Wednesday . The company traded as low as $51.60 and last traded at $51.60, with a volume of 0 shares changing hands. The stock had previously closed at $51.60.

Recordati Industria Chimica e Farmaceutica Stock Performance

The stock has a market capitalization of $10.65 billion, a price-to-earnings ratio of 26.74 and a beta of 0.29. The company has a current ratio of 1.28, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80. The company has a fifty day moving average of $51.60 and a two-hundred day moving average of $48.94.

About Recordati Industria Chimica e Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.

Further Reading

Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.